RSS Feed
Search Ask-Cato.com
Tags
510(k) adverse events ANDA biologics biomarkers biosimilar biotech BLA cancer Cato BioVentures Cato Research CDER CDRH clinical investigator clinical research clinical trials CMC conference CROs drug development eCTD efficacy FDA funding GlobalSubmit guidance IND in vitro diagnostics labeling manufacturing marketing application medical devices NDA nonclinical research oncology Orphan Drug Designations pediatric PMA postmarketing protocol safety statistical analysis transparency venture capital webinarCategories
- Clinical Trials (70)
- Conferences and Meetings (36)
- eCTD (30)
- FDA (110)
- Guest Posts (5)
- Health Canada (7)
- Industry News (88)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (57)
- Social Media (7)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (11)
- Webinars (26)
Tag Archives: India
India: The next up and coming location to run clinical trials?
Until recent years, clinical trials have been conducted primarily in the US and in Europe, due to higher health standards and overall standard of care for patients. However, more and more pharmaceutical companies and contract research organizations (CROs) are … Continue reading
Posted in Clinical Trials, Industry News
Tagged clinical trials, CROs, EMA, FDA, GCP, ICH, India
1 Comment
